m6A-centered Drug Response Information

General Information of the Drug (ID: M6APDG01804)
Name
3,2'-bis-trifluoromethyl-biphenyl-4-carbonitrile
Synonyms
CHEMBL396656; BDBM50220379; 582293-27-4; 3,2''-bis-trifluoromethyl-biphenyl-4-carbonitrile
    Click to Show/Hide
Status
Investigative
Structure
Formula
C15H7F6N
InChI
1S/C15H7F6N/c16-14(17,18)12-4-2-1-3-11(12)9-5-6-10(8-22)13(7-9)15(19,20)21/h1-7H
InChIKey
LVFYAAITUNIVMI-UHFFFAOYSA-N
PubChem CID
44434099
TTD Drug ID
D0G0XB
Target Gene(s) and Their Upstream m6A Regulator, Together with the Effect of Target Gene(s) in Drug Response
The target genes involved in drug-target interaction (such as drug-metabolizing enzymes, drug transporters and therapeutic targets) and drug-mediated cell death signaling (including modulating DNA damage and repair capacity, escaping from drug-induced apoptosis, autophagy, cellular metabolic reprogramming, oncogenic bypass signaling, cell microenvironment, cell stemness, etc.) could be regulated by m6A regulator(s) and affected their corresponding drug response. You can browse detailed information on drug-related target gene(s) mediated by m6A regulators.
Androgen receptor (AR)
ETS-related transcription factor Elf-3 (ELF3)
In total 1 mechanisms lead to this potential drug response
 Regulator Info 
Response Summary Androgen receptor (AR) is a therapeutic target for 3,2'-bis-trifluoromethyl-biphenyl-4-carbonitrile. The ETS-related transcription factor Elf-3 (ELF3) has potential in affecting the response of 3,2'-bis-trifluoromethyl-biphenyl-4-carbonitrile through regulating the expression of Androgen receptor (AR). [1], [2]
References
Ref 1 ELF3 is a repressor of androgen receptor action in prostate cancer cells. Oncogene. 2014 Feb 13;33(7):862-71. doi: 10.1038/onc.2013.15. Epub 2013 Feb 25.
Ref 2 (S)-N-{3-[1-cyclopropyl-1-(2,4-difluoro-phenyl)-ethyl]-1H-indol-7-yl}-methanesulfonamide: a potent, nonsteroidal, functional antagonist of the mineralocorticoid receptor. J Med Chem. 2007 Dec 27;50(26):6443-5. doi: 10.1021/jm701186z. Epub 2007 Nov 27.